Literature DB >> 17579804

Multiple sclerosis with a progressive course from onset in Lorraine-Eastern France.

M Debouverie1, S Louis, S Pittion-Vouyovitch, T Roederer, H Vespignani.   

Abstract

To investigate the patient characteristics, disease progression, and associated risk factors in patients with multiple sclerosis (MS) with a progressive onset, we conducted a longitudinal population-based study of 359 patients (252 with primary progressive MS (PPMS) and 107 with progressive relapsing MS (PRMS)) in Lorraine, France. As outcome measures, we assessed the time from MS onset to reaching disability status scale (DSS) scores of 4, 6 and 7 and the time from assignment of DSS score of 6 to assignment of DSS score of 7. We studied the influence on these outcomes of sex, age of onset and symptoms of onset. We also studied the influence of the time from MS onset to assignment of DSS 6 on the time from MS onset to assignment of DSS 7. There were no significant differences in the demographic data (gender and age at onset of MS) and clinical data (median time to DSS scores of 4, 6 and 7) between the patients with PPMS and PRMS suggesting such a distinction may be unnecessary. The male/female ratio in all 359 patients with MS with a progressive onset was 1/1.36. The median age at onset was 42.7 years (25% Q1 = 34.7; 75% Q3 = 50.0), was lower for male (40.5 years) than for female patients (44.2 years; p = 0.002). The median time to DSS scores of 4, 6 and 7 were (in years) 3.0 (95% CI = 2.8 to 3.7), 9.9 (95% CI = 9.0 to 10.6), and 17.0 (95% CI = 14.9 to 19.0). A cane was required in 25% of patients 5 years after onset and in 75% 15 years after onset. We did not find any significant unfluence of sex, age at onset, or symptoms at onset on the time from MS onset to assignment of scores 6 or 7 or on the time from the assignment of a score of 6 to the assignment of a score of 7.

Entities:  

Mesh:

Year:  2007        PMID: 17579804     DOI: 10.1007/s00415-007-0554-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  27 in total

1.  Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

Authors:  Christian Confavreux; Sandra Vukusic; Patrice Adeleine
Journal:  Brain       Date:  2003-04       Impact factor: 13.501

Review 2.  Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis.

Authors:  Alan Thompson
Journal:  Mult Scler       Date:  2004-06       Impact factor: 6.312

Review 3.  Prognostic factors for multiple sclerosis: the importance of natural history studies.

Authors:  George C Ebers
Journal:  J Neurol       Date:  2005-09       Impact factor: 4.849

4.  Primary progressive multiple sclerosis: a comparative study of the diagnostic criteria.

Authors:  J de Seze; M Debouverie; N Waucquier; G Steinmetz; S Pittion; H Zephir; M Fleury; F Blanc; P Vermersch
Journal:  Mult Scler       Date:  2007-02-16       Impact factor: 6.312

5.  Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study.

Authors:  J M Minderhoud; J H van der Hoeven; A J Prange
Journal:  Acta Neurol Scand       Date:  1988-07       Impact factor: 3.209

6.  Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

Authors:  B Runmarker; O Andersen
Journal:  Brain       Date:  1993-02       Impact factor: 13.501

7.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

8.  Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability.

Authors:  P B Andersson; E Waubant; L Gee; D E Goodkin
Journal:  Arch Neurol       Date:  1999-09

9.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

10.  Primary progressive multiple sclerosis: a 5-year clinical and MR study.

Authors:  G T Ingle; V L Stevenson; D H Miller; A J Thompson
Journal:  Brain       Date:  2003-08-05       Impact factor: 13.501

View more
  3 in total

1.  Epidemiological characteristics and functional disability of multiple sclerosis patients in kosovo.

Authors:  Kamber Zeqiraj; Jera Kruja; Serbeze Kabashi; Sefedin Muçaj
Journal:  Med Arch       Date:  2014-05-31

2.  Estimating typical multiple sclerosis disability progression speed from clinical observations.

Authors:  Murray G Brown; Mark Asbridge; Vern Hicks; Sarah Kirby; Thomas J Murray; Pantelis Andreou; Dong Lin
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

3.  Managing the transition (ManTra): a resource for persons with secondary progressive multiple sclerosis and their health professionals: protocol for a mixed-methods study in Italy.

Authors:  Ambra Mara Giovannetti; Andrea Giordano; Erika Pietrolongo; Paolo Confalonieri; Giovanna De Luca; Carla Tortorella; Maria Trojano; Michele Messmer Uccelli; Valentina Torri Clerici; Lara Gitto; Sascha Köpke; Claudia Borreani; Christoph Heesen; Alessandra Solari
Journal:  BMJ Open       Date:  2017-08-23       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.